Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Jan 04, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000026.pdf 0001968202-24-000026.xls
Jan 04, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000028.pdf 0001968202-24-000028.xls
Jan 04, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000001.pdf 0001883850-24-000001.xls
Jan 04, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000003.pdf 0001883850-24-000003.xls
Jan 04, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000002.pdf 0001883850-24-000002.xls
Jan 04, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000005.pdf 0001883850-24-000005.xls
Jan 04, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000004.pdf 0001883850-24-000004.xls
Jan 04, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000007.pdf 0001883850-24-000007.xls
Jan 04, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000006.pdf 0001883850-24-000006.xls
Jan 04, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000008.pdf 0001883850-24-000008.xls

Data provided by Kaleidoscope.

Investors & Media